Ameriprise
NNVC icon

Ameriprise’s NanoViricides NNVC Stock Holding History

Ameriprise’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5
Closed – – 5862
2014
Q2 		$0 Buy
+5
New +$355 ﹤0.01% 5628

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ameriprise's NNVC Position: Q3 2014 in Review

Ameriprise sold out of NanoViricides (NNVC) in Q3 2014, closing a stake of 5 shares.

Ameriprise first reported a position in NNVC in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 53 funds tracked by Wall St. Rank hold NNVC as of Q3 2014.

  • Ameriprise reported no remaining NanoViricides position as of Q3 2014 after selling out during the quarter.
  • Ameriprise sold 5 NanoViricides shares in Q3 2014.
  • Ameriprise first reported a position in NanoViricides in Q2 2014 and held it in 1 quarter.
  • Ameriprise's NanoViricides position peaked at $0 in Q2 2014.
  • 53 funds tracked by Wall St. Rank held NanoViricides as of Q3 2014.

Based on Ameriprise's 13F filing for Q3 2014, filed 14 Nov 2014.